EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment

Nadia Merchant iD, Julie Hoover-Fong iD, Ricki S Carroll iD

The Journal of Clinical Endocrinology & Metabolism · 17.06.2025 · 110 (7) · e2309-e2316

DOI: 10.1210/clinem/dgaf017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 15.01.2025. Verfasst von Nadia Merchant und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Achondroplasia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achondroplasia is the most common disproportionate short-stature skeletal dysplasia. Features associated with achondroplasia are rhizomelia, macrocephaly, midface hypoplasia, and typical cognition. Potential medical complications include foramen magnum stenosis, hydrocephalus, middle ear dysfunction, obstructive and central sleep apnea, spinal stenosis, and genu varum. Recently, vosoritide, a C-type natriuretic peptide analogue, was approved by the Food and Drug Administration with the primary indication of increasing linear growth in all children with achondroplasia and open growth plates. Due to this, pediatric endocrinologists suddenly are encountering infants and children with achondroplasia in their clinic whose families are seeking treatment with vosoritide. There is an urgent need to provide practical guidance pertaining to the diagnosis, management, and surveillance of these patients. Specific to current clinical use of vosoritide and other growth-modulating therapies in development for patients with achondroplasia, it is important to recognize that 1. some children and their families do not automatically desire such treatment, 2. not all treated children exhibit a response in linear growth, and 3. treatment does not negate the necessity of actively surveilling for the potential complications of achondroplasia that are part of its natural history. The goal of this paper is to provide probable, contemporary clinical scenarios of infants and children with achondroplasia who may present to an endocrinologist. This information is especially crucial to the endocrinologist when there is no specialized skeletal dysplasia center near the family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AchondroplasiaHumansChildNatriuretic Peptide, C-TypeInfant

Stichwörter der Autor:innen

CNPachondroplasiaforamen magnum stenosisskeletal dysplasiavosoritide

Substanzen

Natriuretic Peptide, C-Type

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Greenberg Center for Skeletal Dysplasias, Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD 21218, USA.
  • Division of Orthogenetics, Department of Pediatrics, Nemours Children's Hospital, Delaware, Wilmington, DE 19803, USA.

ORCID-Profile: Nadia Merchant, Julie Hoover-Fong, Ricki S Carroll

Zitieren

APA

Merchant, N., Hoover-Fong, J., & Carroll, R. S. (2025). Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment. The Journal of Clinical Endocrinology & Metabolism, 110(7), e2309-e2316. https://doi.org/10.1210/clinem/dgaf017

Vancouver

Merchant N, Hoover-Fong J, Carroll RS. Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment. The Journal of Clinical Endocrinology & Metabolism. 2025;110(7):e2309-e2316. doi:10.1210/clinem/dgaf017

BibTeX
@article{Merchant2025,
  author = {Merchant, Nadia and Hoover-Fong, Julie and Carroll, Ricki S},
  title = {Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {7},
  pages = {e2309--e2316},
  doi = {10.1210/clinem/dgaf017}
}
Kostenlos starten →